Target intelligence / Profile preview

Inositol 1,4,5-trisphosphate receptor (IP3R)

Target
IP3R
Molecular classification
Ion channel, Receptor
01

Overview

The Inositol 1,4,5-trisphosphate receptor (IP3R) is a family of ligand-gated intracellular calcium release channels predominantly localized on the membrane of the endoplasmic and sarcoplasmic reticulum. Comprising three distinct mammalian isoforms (IP3R1, IP3R2, and IP3R3), these tetrameric channels open in response to the binding of the second messenger inositol 1,4,5-trisphosphate (IP3) and cytosolic calcium, facilitating the rapid efflux of calcium ions into the cytoplasm. This IP3 receptor-dependent calcium release machinery plays a fundamental role in regulating diverse cellular processes, including signal transduction, gene transcription, cell proliferation, apoptosis, and mitochondrial bioenergetics. Dysregulation of IP3R-mediated calcium signaling is implicated in a wide range of human pathologies, such as neurodegenerative disorders (e.g., spinocerebellar ataxias and Huntington's disease), cardiovascular diseases (e.g., cardiac hypertrophy, heart failure, and arrhythmias), and various cancers where altered IP3R expression supports tumor cell survival and invasion. Pharmacological modulation of IP3Rs represents a promising therapeutic strategy, with research focusing on small-molecule inhibitors like 2-APB, xestospongins, and subtype-selective peptide inhibitors to normalize calcium homeostasis in diseased states. However, the ubiquitous expression of IP3Rs and the lack of highly selective, clinically viable modulators present significant therapeutic challenges and safety concerns.

Other names
IP3 receptorInositol trisphosphate receptorITPRIP3 receptor-dependent Ca2+ release machinery
02

Mechanism of action

Inositol 1,4,5-trisphosphate receptor antagonist, agonist, or modulator

03

Biological functions

Signal transductionApoptosisCell proliferationCell deathOther
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerOther
05

Safety considerations

Off-target effects on other calcium channelsSystemic toxicity due to ubiquitous expressionDisruption of essential calcium-dependent cellular processesPotential to trigger apoptosis in healthy tissues
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

ITPR1 expressionITPR2 expressionITPR3 expressionCytosolic calcium levels

Beyond the preview

Go deeper on Inositol 1,4,5-trisphosphate receptor (IP3R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inositol 1,4,5-trisphosphate receptor (IP3R).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call